HNRNPH1 ‐related syndromic intellectual disability: Seven additional cases suggestive of a distinct syndromic neurodevelopmental syndrome by Reichert, Sara Chadwick et al.
Title:   HNRNPH1-related syndromic intellectual disability: Seven additional cases suggestive of 
a distinct syndromic neurodevelopmental syndrome.    
Short running title:  HNRNPH1-related intellectual disability 













, Marie-José H. van den Boogaard
3






















, Elisa De Franco
11









Department of Human and Molecular Genetics, Clinical Genetics Services. VCU Health.  Richmond, VA 23298, 
USA 
2
Department of Pathology.  VCU Health.  Richmond, VA 23298, USA. 
3
Department of Genetics, University Medical Center Utrecht.  Utrecht, the Netherlands. 
4
Pediatric Neurology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, 
CIBERER, Barcelona, Spain. 
5
Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, 
Barcelona, Catalonia, Spain. 
6
Centre for Biomedical Research on Rare Diseases (CIBERER), Institute Carlos III, Madrid, Spain. 
7
Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. 
8 
Laboratorio Genetica Medica, ASST Papa Giovanni XXIII, Bergamo, Italy. 
9 
Clinical Pediatric Genetic Unit, Pediatric Clinic, Fondazione MBBM, San Gerardo Hospital, Monza. 
10 
Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK 
11 
College of Medicine and Health. University of Exeter Medical School, Exeter UK. 










This article has been accepted for publication and undergone full peer review but has 
not been through the copyediting, typesetting, pagination and proofreading process 
which may lead to differences between this version and the Version of Record. Please 
cite this article as doi: 10.1111/cge.13765 
 
12
Department of Pediatrics. University of Maryland School of Medicine.  Baltimore, MD, USA 
*Correspondence:  sara.reichert@vcuhealth.org, 804.828.5783 
 
Acknowledgments:    
We gratefully acknowledge all the individuals and their families.    
The work was funded by “Progetti di innovazione in ambito sanitario e 
socio sanitario Regione Lombardia, bando ex decreto n. 2713 del 28/02/2018” as part of the” 
GENE - Genomic analysis Evaluation NEtwork “ project (MI)   
This work was supported by the Centre for Biomedical Research on Rare Diseases (CIBERER) 
[ACCI14-759], the URDCat program (PERIS SLT002/16/00174), the Hesperia Foundation 
and the Secretariat for Universities and Research of the Ministry of Business and Knowledge of 
the Government of Catalonia [2017SGR1206] to AP  
S.E. is a Wellcome Senior Investigator. 
 
Conflict of Interest: 
There are no conflicts of interest to disclose among the authors included in the preparation and 
publication of this manuscript.  
 
Data Availability Statement: 
There are no other data associated with this manuscript. 











Abstract   
Pathogenic variants in HNRNPH1 were first reported in 2018.  The reported individual, a 13 year 
old boy with a c.616C>T (p.R206W) variant in the HNRNPH1 gene, was noted to have 
overlapping symptoms with those observed in HNRNPH2-related X-linked intellectual disability, 
Bain type (MRXSB), specifically intellectual disability and dysmorphic features.  While 
HNRNPH1 variants were initially proposed to represent an autosomal cause of MRXSB, we 
report an additional seven cases which identify phenotypic differences from MRXSB.    Patients 
with HNRNPH1 pathogenic variants diagnosed via WES were identified using clinical networks 
and GeneMatcher.    Features unique to individuals with HNRNPH1 variants include distinctive 
dysmorphic facial features; an increased incidence of congenital anomalies including cranial and 
brain abnormalities, genitourinary malformations, and palate abnormalities; increased incidence 
of ophthalmologic abnormalities; and a decreased incidence of epilepsy and cardiac defects 
compared to those with MRXSB.  This suggests that pathogenic variants in HNRNPH1 result in 
a related, but distinct syndromic cause of intellectual disability from MRXSB, which we refer to 
as HNRNPH1-related intellectual disability.   
 
Key Words:  Whole exome Sequencing, intellectual disability, microcephaly,  congenital 
abnormalities, HNRNPH1 gene 
 
 











The HNRNPH1 [MIM 601035] and HNRNPH2 [MIM 300986] genes produce the hnRNP 
H and hnRNP H’ (also called hnRNP H2) proteins, respectively.  These proteins belong to the 
heterogeneous nuclear ribonucleoprotein (hnRNP) family of RNA binding proteins which bind 
to pre-mRNA transcripts and assist in stabilizing, transporting, and targeting transcripts between 
the nucleus and cytoplasm for processing and alternative splicing prior to becoming mature 
mRNAs.
1
  More than 20 hnRNPs have been identified, and hnRNP H and hnRNP H’ share 96% 
homology. Both genes are ubiquitously expressed across multiple tissue types including the 
brain, eye, smooth muscle, small intestine, and stomach.
2
  The functions of hnRNP H and H’ on 
pre-mRNA processing include capping, splicing, polyadenylation, export, and translation and are 
mainly exerted within the nucleus.
3
 
Given their central role in cellular function, it is not surprising that pathogenic variants 
affecting genes that code for hnRNPs are an emerging cause of disease.  Altered expression of 
hnRNPs has been linked to tumorigenesis and  germline variants in genes encoding hnRNPs 
have been implicated as a potential causes of adult-onset neurodegenerative conditions including 
frontotemporal dementia/amyotrophic lateral sclerosis, inclusion body myopathy with 
frontotemporal dementia (IBMPFM [MIM: 615424]), and Alzheimer disease.
1,4
 Whole exome 
sequencing (WES) has identified multiple HNRNP genes as novel causes of early-onset 
syndromic intellectual disability.
5-7 
In 2016, pathogenic variants in HNRNPH2 were reported as a novel cause for an X-
linked intellectual disability syndrome in females
.6
  This new syndrome, HNRNPH2-related X-
linked intellectual disability, Bain type, (MRXSB [MIM: 300986]), was characterized by 
intellectual disability, dysmorphic features, feeding difficulties, seizures, and hypotonia.  While 










originally thought that pathogenic variants would be lethal in males, three groups have reported 
four males with pathogenic variants in HNRNPH2 and symptoms consistent with MRXSB.
8-10 
Among the eleven cases of MRXSB reported to date, seven have a common c.616C>T 
(p.R206W) variant, while another two have c.617G>A (p.R206Q) variants. The remaining two 
male cases carry c.626C>T (p.P209L) and c.340C>T (p.R114W) variants. 
The first pathogenic variant in HNRNPH1 was reported by Pilch et al. in 2018.
11
 In the 
reported individual, a 13-year-old boy, a de novo c.616C>T (p.R206W) variant in HNRNPH1 
was identified by WES.  His phenotype included dysmorphic facial features, microcephaly, 
hypermobile joints, hypotonia, non-verbal intellectual disability, and feeding difficulties.
11
 Given 
the similar phenotypes, the conserved amino acid sequences at position 206 of hnRNP H and H’, 
and the overall homology between these proteins, it was postulated that variants in HNRNPH1 
may represent an autosomal cause of MRXSB.  However, some features reported by Pilch et al. 
were not observed in the MRXSB cohort, including arched eyebrows, blepharophimosis, 
congenital microcephaly, and hip dislocations. 
Here, we present an additional seven cases of de novo pathogenic variants in HNRNPH1 




Materials and methods: 










Seven individuals with HNRNPH1 pathogenic variants were identified using 
GeneMatcher and clinical networks.
12
 One individual resides in the United States, the remaining 
in the European Union. DNA extracted form peripheral blood was analyzed by WES on all 
individuals using standard technologies.  Details on case specific WES can be found in 
Supporting Materials.  This series was reviewed by the VCU Health IRB and not found to meet 
the definitions of human subjects research, and thus did not require IRB review or approval.  
Written informed consent was obtained for individuals whose photographs are included within 
this report.  We characterized their phenotype retrospectively and contrasted them with features 
reported previously by Pilch et al. as well as with individuals with MRXSB.    
Results: 
The seven individuals range in age from a fetus at 30w4d to a 23-year-old. The five 
surviving cases have intellectual disability, ranging from moderate to severe.   Congenital 
anomalies were observed in this cohort, with 7/7 having abnormalities identified on brain MRI, 
4/7 having palate abnormalities, and 3/7 having genitourinary malformations.  Other notable 
features observed include ophthalmological abnormalities (6/7), short stature (5/7), microcephaly 
(5/7), and hypotonia (4/7).  Developmental regression is not observed in this cohort.  4/6 
surviving individuals are non-verbal or have very limited speech.  A complete phenotypic review 
can be found in Table 1. Dysmorphic features were also observed within our cohort, including 
medial arched eyebrows (4/7), blepharophimosis (3/7), ptosis (3/7), and hypotelorism (3/7).  
(Figure 1, Table S1).   These features are similar to what was reported by Pilch et al.
11
 Additional 
clinical history can be found in Supporting Materials.  
Overlapping features with MRXSB include intellectual disability, microcephaly, and 
gastrointestinal abnormalities.  However, our cohort has other anomalies not consistently 










reported among individuals with MRXSB. These include cerebellar anomalies, palate 
abnormalities, genitourinary abnormalities, micrognathia, and short stature. 3/7 individuals in 
this cohort were noted to have dystonia, versus 1/11 individuals with MRXSB.   Individuals in 
this cohort were also more frequently observed to have ophthalmological abnormalities, most 
often strabismus. Epilepsy, reported in 5/11 individuals with MRXSB, was only observed in 2/7 
individuals within our cohort.   The constellation of dysmorphic facial features observed in this 
cohort also suggests a distinct phenotype when compared with MRXSB.  Congenital 
microcephaly, blepharophimosis, ptosis, hypotelorism, posteriorly rotated hypoplastic ears, 
medial arched eyebrows, open bite, and syndactyly/clinodactyly are features observed in 
individuals with HNRNPH1 pathogenic variants but not widely reported in MRXSB.     
Six variants were identified in this cohort including two missense variants, two frameshift 
variants, an in-frame deletion, and an entire gene duplication (Figure 2).  One variant, c.616C>T 
(p.R206W) identified in Cases 1 and 7, was previously described by Pilch et al.
11
  Another, 
c.617G>A (p.R206Q) was identified in Case 4 and is analogous to the HNRNPH2 variant 
described by Bain et al.
6
  The remaining four variants have not been described in either 
HNRNPH1 or HNRNPH2 to date.  These include two small duplications, c.618dupG 
(p.Pro207fs) and c.1240_1243dup (p.Q415fs) and one in-frame deletion, c.1116_1175del 
(p.Glu373-Tyr392del).  The final variant is a large duplication encompassing both the  
HNRNPH1 and RUFY1 [MIM 610327] genes.   
Discussion: 
The seven individuals reported in this series suggest a unique, but variable, phenotype 
due to pathogenic HNRNPH1 variants.  We hypothesize that much of the clinical variability 
observed among our cohort may be due to genotype/phenotype correlations. The hnRNP H and 










H’ proteins have three highly homologous RNA recognition motifs that allow them to 
specifically bind to G-rich RNA.
1
  In addition, they also have two glycine-rich domains, 
designated GYR and GY.  A non-classical nuclear localization sequence (NLS) has been 
identified within the GYR region between amino acids 194 and 220 with amino acids 205-213 
being highly conserved and required for nuclear transport.
3 
In vitro studies introducing point 
mutations into this NLS resulted in failure of these hnRNPs to shuttle from the cytoplasm to the 
nucleus, which is expected to compromise function.
3
 
Individuals with missense variants affecting amino acids 206-208 appear to have a more 
severe clinical phenotype.  This is likely because these variants are predicted to disrupt the NLS, 
thus impacting the overall function on the hnRNP H protein.
6,11
 Individuals observed with the 
recurrent c.616C>T and c.617G>A variants (Cases 1, 7, and 4) presented immediately following 
birth or prenatally with issues including microcephaly, respiratory distress, hypotonia, and 
congenital anomalies.  This early-onset severe presentation further highlights the importance of 
the NLS sequence in the hnRNP H protein and suggests that disruption of this sequence has 
severe clinical consequences. 
The two frameshift variants reported in this cohort, c.618dupG (p.207fs) and 
c.1240_1243dup (c.Q415fs), are expected to result in either an abnormal, truncated protein or 
loss of protein from nonsense mediated mRNA decay.  c.618dupG falls within the NLS and 
c.1240_1243dup in the GY domain.  The discordant phenotypes of these two individuals with 
frameshift mutations may reflect the severity of the frameshift on the overall protein structure. 
As c.618dupG (p.P207fs) lies within the NLS, it is predicted to produce a protein with a 
malfunctioning NLS.  This supports the above suggestion that disruption of the NLS results in 
severe clinical consequences, as Case 2, found to have c.618dupG (p.P207fs), presented with 










hypotonia, respiratory distress, and congenital anomalies, similar to those with missense variants 
in the NLS.  In contrast, Case 6, found to have c.1240_1243dup (p.Q415fs), has a less severe 
phenotype compared to cases 1, 2, 4, and 7.  Case 6 did not come to medical attention in the 
neonatal period, is not noted to have microcephaly, and does not have palate abnormalities, short 
stature, or clinodactyly/syndactyly.  Case 6 also has milder intellectual disability compared to 
other cases.  Because c.1240_1243dup lies within the GY domain, it is predicted to impact the 
protein after the NLS, possibly resulting in an abnormal protein that may have a functional NLS 
region, which may ameliorate the severity of the observed phenotype.     
Of the remaining HNRNPH1 variants, one falls in the GY domain, c.1116_1175del 
(p.Glu373-Tyr392del) (Case 5), and is expected to remove 19 amino acids.  The function of the 
GY domain is not as well understood as the GYR domain, however it is thought to be important 
for protein-protein interactions and splicing.
3
 Thus, these pathogenic variants may have 
functional implications on protein/protein or protein/RNA interactions however it is difficult to 
say without additional functional studies.   Case 5 has a less severe phenotype compared to those 
with pathogenic variants within the NLS, similar to Case 6 with a normal neonatal period, milder 
intellectual disability, and no microcephaly.    
The final variant reported is an entire gene duplication of  HNRNPH1 and RUFY1 (Case 
3).  This de novo 100.1kb duplication was consistently identified by WES and whole genome 
sequencing (WGS) independently, with coordinates identified by three different CNV 
identification tools, ExomeDepth v1.1.10, XHMM and Conifer v0.2.2 (Figure S1).    To confirm 
this duplication, a qPCR assay was run on fibroblasts from the proband and parents to confirm 
the de novo duplication (Figure S1). The RUFY1 gene encodes the RUN and FYVE domain 
containing 1 protein, and is thought to be involved in early endosomal trafficking.
13
  To date, no 










human disease has been associated with the RUFY1 gene.  The impact of this HNRNPH1 gene 
duplication on protein function is unclear, however given the overlap of features observed in 
other individuals with missense, frameshift, and small deletions within HNRNPH1, it is likely 
that it would result in abnormal hnRNP H function. It is also worth considering that a small 
rearrangement within the duplicated region can not be ruled out, as it would go undetected by 
short read WES or WGS. Further functional studies are required to better understand the 
implications of this duplication on protein function.  The clinical features of Case 3 are not as 
severe as those with pathogenic variants impacting the NLS, however they are more severe than 
those with pathogenic variants in the GY glycine rich domain.  Specifically, Case 3 was found to 
have white matter and cerebellar abnormalities,dysmorphic features,  short stature, genitourinary 
abnormalities, and microcephaly along with dysmorphic traits present in other reported cases. 
However, he has moderate intellectual disability, is verbal, and is ambulatory. 
While limited due to a small number of individuals, these findings provide additional 
evidence that pathogenic variants in HNRNPH1 cause a related, but unique syndrome from 
MRXSB. Given the observations presented in this report, genotype/phenotype correlation does 
appear to exist, since individuals with variants impacting the NLS have a more severe phenotype. 
Given the absence of predicted loss of function variants in healthy controls, haploinsufficiency is 
a likely pathogenic mechanism for variants in HNRNPH1.  Future endeavors focusing on 
functional studies will provide insights into the pathological mechanisms of HNRNPH1 variants.  
Our findings suggest that pathogenic variants in HNRNPH1 represent a related, but 
distinct, syndrome from MRXSB with unique dysmorphic features, increased incidence of 
congenital anomalies, and an increased incidence of ophthalmological abnormalities. 
Importantly, identification of additional individuals with pathogenic HNRNPH1 variants will 










continue to shape the observed phenotype and provide further insights into the potential 
genotype/phenotype correlation.   While this represents a rare form of syndromic intellectual 
disability, given the severity observed in individuals with variants impacting the NLS, 
consideration of rapid-WES in critically ill newborns with microcephaly, congenital anomalies, 
and respiratory distress may identify pathogenic variants in HNRNPH1.  Common features 
reported among the majority of individuals with HNRNPH1 variants include short stature, 
microcephaly, intellectual disability, congenital anomalies, and dysmorphic features, specifically 
blepharophimosis, ptosis, hypotelorism, medial arched eyebrows, and micrognathia. We 
therefore propose that individuals with HNRNPH1 pathogenic variants be described as having 
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Table 1. Clinical characteristics of Individuals with HNRNPH1 variants (NM 005520.2) in comparison with individuals with HNRNPH2-related X-
linked intellectual disability, Bain type (MRXSB).  Abbreviations are as follows: (+), present; (-), not present; (+/-), mild; (FTT), Failure to Thrive; (GERD), 
gastroesophageal reflux disease; (d), deceased. 
 
 
MRXSB         
    (n=11) 
Pilch et al. 
2018 




c.616C>T        
    (p>R206W) 
n=7, 
c.617G>A 


























Sex 7F, 4M M M M M M F F M 2F, 6M 
Age 
 
13y 14 y 11y 14y 30w3d (d) 5 years 23 years 10.5 m (d) 30w3d – 14y 
Intellectual 
disability 
+ (11/11) + + + + 
 
+ + 






Variable:         
   nonverbal to 
short 
sentences 












+ (2/11) + - + + 
 
+ - + 5/8 
Other Brain 
Abnormalities 
+            
(1/11) Lipoma 











































Joint laxity + (3/11) + + + - 
 
- +  4/8 
Short stature + (4/11) + + + + + (IUGR) 
 
- + 6/8 
Skeletal Issues 













lordosis   











































+ Hypotonia + Hypotonia + Hypotonia + Hypertonia 
  










Cryptorchidism   
- Cryptoorchidism 4/8 
Ophthalmologic 
findings 
+            















































































Figure 1: Dysmorphic Features in Affected Individuals.  Photographs of Case 1 at 14 years of age (1A-1D) with dysmorphic features including long face, 
hypotelorism, belpharophimosis, ptosis, downslanting palpebral fissures, medial arched eyebrows, long prominent nose with hypoplastic alae nasi and low 
hanging columella, small mouth, open bite, micrognathia, posteriorly rotated hypoplastic ears, arachnodactyly, clinodactyly, campodactyly, and clubbed 
fingers.  Photographs of Case 2 at 1 week, 3 years, 8 years, and 11 years of age respectively (2A-D) with dysmorphic features including belpharophimosis, ptosis, 
medial arched eyebrows, mild downslanting palpebral fissures, hypoplastic alae nasi, micrognathia, posteriorly rotated hypoplastic ears, and open bite. Case 2 
was also noted to have clinodactyly (not shown).  Photographs at Case 3 at 14 years of age (3A-B) with dysmorphic features including blepharophimosis, medial 
arched eyebrows, hypoplastic alae nasi, micrognathia, and posteriorly rotated ears. 
 
Figure 2:    Characteristics of HNRNPH1 pathogenic variants.  A. Location of HNRNPH1 pathogenic variants in the HNRNP H protein.  B. Predicted 
pathogenicity and mutational consequence of HNRNPH1 pathogenic variants.    
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